Skip to main content

Post-IPO Debt Pharmaceutical Companies

Explore 65 pharmaceutical startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
65
Total Funding
$1.6B
Avg Funding
$62.2M
Cities
21

Export 65 Post-IPO Debt Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Chicago, United States
$26.0M
raised

Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Malvern, United States
$60.0M
raised

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$2.9M
raised

Rubicon Organics is at the forefront of advancements with the production of clean, craft-style, affordable, organic cannabis products.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Novato, United States
$400.0M
raised

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$1.1M
raised

Christina Lake Cannabis focuses on oil extraction that provides for more significant margin opportunities.

Oct 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$100.0M
raised

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

Sep 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$125.0M
raised

KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.

Sep 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Conshohocken, United States
$350.0M
raised

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Jul 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ansager, Denmark
$315K
raised

Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.

Jul 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Helsinki, Finland
$5.8M
raised

Nanoform is a pioneering company driven by a passion for innovation and a commitment to solving our partners’ problems.

Jun 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Irvine, United States
$150.0M
raised

Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.

May 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$96.5M
raised

FLUENT utilizes capital and expertise in making strategic investments to help launch mature and professional cannabis markets.

Nov 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Caledon, Canada
$78.6M
raised

HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity.

Aug 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Lexington, United States
$125.0M
raised

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Aug 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$733K
raised

Cessatech is a pharmaceutical company.

Aug 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Fort Lauderdale, United States
$3.5M
raised

Bright Green produces cannabis-related products, and plant-based medicines for research and pharmaceutical purposes.

Aug 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

$5.8M
raised

MindMaze formerly Relief Therapeutics develops biopharmaceutical and neurotechnology solutions for neurological and rare diseases.

Aug 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$219K
raised

Core One Labs produces cannabis for oral consumption.

Jun 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$291K
raised

CS MEDICA is a medical equipment manufacturing and distribution company focused on the treatment of autoimmune and stress-related disorders.

May 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$714K
raised

OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.

Feb 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 65 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Scottsdale, United States
$20.0M
raised

Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc. (FBIO).

Jan 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Sydney, Australia
$410K
raised

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs.

Nov 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vaughan, Canada
$400K
raised

Mednow is a healthcare technology company that offers free at-home delivery of medications and access to telemedicine virtual care.

Jul 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$299K
raised

Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.

Jul 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Newton, United States
$1.0M
raised

Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.

Jun 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 65 companies

Ready to Connect with Post-IPO Debt Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 65 post-ipo debt pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked